The Coming Rise of tRNA Therapies

When Daniel Fischer cofounded Tevard Biosciences in 2017, he wasn’t trying to bet on the next hot RNA technology. His interest was more personal. His daughter Natasha has Dravet syndrome, a rare form of epilepsy caused by a genetic glitch in a type of sodium channel.

Read Full Article »

Show comments Hide Comments

Related Articles